Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Guardion Health Sciences stock | $1.5

Learn how to easily invest in Guardion Health Sciences stock.

Guardion Health Sciences Inc is a drug manufacturers-specialty & generic business based in the US. Guardion Health Sciences shares (GHSI) are listed on the NASDAQ and all prices are listed in US Dollars. Guardion Health Sciences employs 12 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Guardion Health Sciences

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GHSI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Guardion Health Sciences stock price (NASDAQ: GHSI)

Use our graph to track the performance of GHSI stocks over time.

Guardion Health Sciences shares at a glance

Information last updated 2021-10-25.
Latest market close$1.50
52-week range$0.96 - $8.40
50-day moving average $1.16
200-day moving average $1.46
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.68

Buy Guardion Health Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Guardion Health Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Guardion Health Sciences price performance over time

Historical closes compared with the close of $1.5 from 2021-10-27

1 week (2021-10-21) 41.51%
1 month (2021-09-28) 18.11%
3 months (2021-07-28) 6.38%
6 months (2021-04-28) -17.58%
1 year (2020-10-27) 38.12%
2 years (2019-10-25) -42.40%
3 years (2018-10-24) N/A
5 years (2016-10-24) N/A

Guardion Health Sciences financials

Revenue TTM $1.9 million
Gross profit TTM $-56,791
Return on assets TTM -23.94%
Return on equity TTM -48.96%
Profit margin 0%
Book value $1.61
Market capitalisation $24.7 million

TTM: trailing 12 months

Shorting Guardion Health Sciences shares

There are currently 452,186 Guardion Health Sciences shares held short by investors – that's known as Guardion Health Sciences's "short interest". This figure is 152% up from 179,426 last month.

There are a few different ways that this level of interest in shorting Guardion Health Sciences shares can be evaluated.

Guardion Health Sciences's "short interest ratio" (SIR)

Guardion Health Sciences's "short interest ratio" (SIR) is the quantity of Guardion Health Sciences shares currently shorted divided by the average quantity of Guardion Health Sciences shares traded daily (recently around 233085.56701031). Guardion Health Sciences's SIR currently stands at 1.94. In other words for every 100,000 Guardion Health Sciences shares traded daily on the market, roughly 1940 shares are currently held short.

However Guardion Health Sciences's short interest can also be evaluated against the total number of Guardion Health Sciences shares, or, against the total number of tradable Guardion Health Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Guardion Health Sciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Guardion Health Sciences shares in existence, roughly 20 shares are currently held short) or 0.019% of the tradable shares (for every 100,000 tradable Guardion Health Sciences shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Guardion Health Sciences.

Find out more about how you can short Guardion Health Sciences stock.

Guardion Health Sciences share dividends

We're not expecting Guardion Health Sciences to pay a dividend over the next 12 months.

Have Guardion Health Sciences's shares ever split?

Guardion Health Sciences's shares were split on a 1:6 basis on 28 February 2021. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Guardion Health Sciences shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Guardion Health Sciences shares which in turn could have impacted Guardion Health Sciences's share price.

Guardion Health Sciences share price volatility

Over the last 12 months, Guardion Health Sciences's shares have ranged in value from as little as $0.96 up to $8.4. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Guardion Health Sciences's is 0.0623. This would suggest that Guardion Health Sciences's shares are less volatile than average (for this exchange).

Guardion Health Sciences overview

Guardion Health Sciences, Inc. , together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.

Frequently asked questions

What percentage of Guardion Health Sciences is owned by insiders or institutions?
Currently 3.422% of Guardion Health Sciences shares are held by insiders and 11.171% by institutions.
How many people work for Guardion Health Sciences?
Latest data suggests 12 work at Guardion Health Sciences.
When does the fiscal year end for Guardion Health Sciences?
Guardion Health Sciences's fiscal year ends in December.
Where is Guardion Health Sciences based?
Guardion Health Sciences's address is: 15150 Avenue of Science, San Diego, CA, United States, 92128
What is Guardion Health Sciences's ISIN number?
Guardion Health Sciences's international securities identification number is: US40145Q4010
What is Guardion Health Sciences's CUSIP number?
Guardion Health Sciences's Committee on Uniform Securities Identification Procedures number is: 40145Q104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site